Postpartum Glycemia in Women At Risk for Persistent Hyperglycemia

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 17, 2021

Primary Completion Date

December 10, 2024

Study Completion Date

December 10, 2024

Conditions
Gestational Diabetes
Interventions
DIAGNOSTIC_TEST

2-hour 75-g oral glucose tolerance test and Dexcom G6 Pro continuous glucose monitor

All women enrolled in this study will have a 2-hour 75-g oral glucose tolerance test performed immediately postpartum (within 4 days of delivery), at 4-6 weeks postpartum, and at 6 months postpartum. Enrolled women will also wear a continuous glucose monitor for 10 days at each of these time periods. Both women and their infants will have skin fold thickness measured at each of these 3 study visits to estimate body fat composition. Additionally umbilical cord blood and placental biopsies will be collected at delivery and stored for future research.

Trial Locations (2)

27514

University of North Carolina at Chapel Hill, Chapel Hill

35233

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

University of North Carolina, Chapel Hill

OTHER

lead

University of Alabama at Birmingham

OTHER

NCT04521712 - Postpartum Glycemia in Women At Risk for Persistent Hyperglycemia | Biotech Hunter | Biotech Hunter